A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W. Glickman, Ester Del Duca, John K Nia, Peter W. Hashim, Giselle Singer, Alba Posligua, Aleksandra G. Florek, Erin Ibler, Erika L. Hagstrom, Yeriel Estrada, Stephanie M. Rangel, Maria Colavincenzo, Amy S. Paller, Emma Guttman‐Yassky
Topics & Concepts
Alopecia areataMedicineAdverse effectClinical endpointRandomized controlled trialHair lossAlopecia universalisDermatologyClinical trialScalpInternal medicineEczema Area and Severity IndexHair Growth and DisordersDermatology and Skin DiseasesAutoimmune Bullous Skin Diseases